26103-48-0 Usage
General Description
4-(Pyridin-3-ylsulphonyl)morpholine is a chemical compound with the molecular formula C9H10N2O2S. It is a heterocyclic compound that contains a morpholine ring and a pyridine moiety attached to a sulphonyl group. 4-(Pyridin-3-ylsulphonyl)morpholine is primarily used as a reagent in organic synthesis and pharmaceutical research. It has been reported to have potential medicinal properties, particularly as an inhibitor of certain enzymes, and is being investigated for its potential use in the treatment of various diseases. Additionally, it is used as a building block in the synthesis of other complex molecules. Due to its unique structure and potential versatile applications, 4-(Pyridin-3-ylsulphonyl)morpholine is of interest to researchers in the fields of chemistry and medicinal chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 26103-48-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,6,1,0 and 3 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 26103-48:
(7*2)+(6*6)+(5*1)+(4*0)+(3*3)+(2*4)+(1*8)=80
80 % 10 = 0
So 26103-48-0 is a valid CAS Registry Number.
InChI:InChI=1/C9H12N2O3S/c12-15(13,9-2-1-3-10-8-9)11-4-6-14-7-5-11/h1-3,8H,4-7H2
26103-48-0Relevant articles and documents
Copper-catalyzed electrophilic amination of sodium sulfinates at room temperature
Zhu, Haibo,Shen, Yajing,Deng, Qinyue,Tu, Tao
supporting information, p. 16573 - 16576 (2015/11/18)
By using O-benzoyl hydroxylamines as amine sources, the first convenient copper-catalyzed electrophilic amination of sodium sulfinates has been realized. Even with 2 mol% catalyst loading, the protocol provided an efficient and straightforward synthesis of a broad range of functional sulfonamides under ambient reaction conditions without an additional base and ligand. Based on the control experiments, a plausible mechanism was proposed.
Acetyl-CoA carboxylase inhibitors
-
, (2008/06/13)
Acetyl Coenzyme A Carboxylase inhibitors, pharmaceutical compositions containing such compounds and the use of such compounds to treat for example, Metabolic Syndrome including atherosclerosis, diabetes and obesity.
